Literature DB >> 15196919

Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine.

Julian L Griffin1, Daniel C Anthony, Sandra J Campbell, Jack Gauldie, Fernando Pitossi, Peter Styles, Nicola R Sibson.   

Abstract

Multiple sclerosis is a major cause of non-traumatic neurological disability. The identification of markers that differentiate disease progression is critical to effective therapy. A combination of NMR spectroscopic metabolic profiling of urine and statistical pattern recognition was used to detect focal inflammatory central nervous system (CNS) lesions induced by microinjection of a replication-deficient recombinant adenovirus expressing TNF-alpha or IL1-beta cDNA into the brains of Wistar rats. These animals were compared with a group of naïve rats and a group of animals injected with an equivalent null adenovirus. Urine samples were collected 7 days after adenovirus injection, when the inflammatory lesion is maximally active. Principal components analysis and Partial Least Squares-Discriminate analysis of the urine (1)H NMR spectra revealed significant differences between each of the cytokine adenovirus groups and the control groups; for the TNF-alpha group the main differences lay in citrate and succinate, while for the IL-1beta group the predominant changes occurred in leucine, isoleucine, valine and myo-inositol. Thus, we can identify urinary metabolic vectors that not only separate rats with inflammatory lesions in the brain from control animals, but also distinguish between different types of CNS inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196919     DOI: 10.1016/j.febslet.2004.04.096

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Metabolomics--a novel window into inflammatory disease.

Authors:  Martin Fitzpatrick; Stephen P Young
Journal:  Swiss Med Wkly       Date:  2013-01-21       Impact factor: 2.193

2.  A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Authors:  Alex M Dickens; James R Larkin; Julian L Griffin; Ana Cavey; Lucy Matthews; Martin R Turner; Gordon K Wilcock; Benjamin G Davis; Timothy D W Claridge; Jacqueline Palace; Daniel C Anthony; Nicola R Sibson
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

3.  Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.

Authors:  James R Larkin; Alex M Dickens; Timothy D W Claridge; Claire Bristow; Kleopatra Andreou; Daniel C Anthony; Nicola R Sibson
Journal:  Theranostics       Date:  2016-09-12       Impact factor: 11.556

4.  Cerebral biochemical pathways in experimental autoimmune encephalomyelitis and adjuvant arthritis: a comparative metabolomic study.

Authors:  Norbert W Lutz; Carla Fernandez; Jean-François Pellissier; Patrick J Cozzone; Evelyne Béraud
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

5.  NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.

Authors:  Alex M Dickens; James R Larkin; Benjamin G Davis; Julian L Griffin; Timothy D W Claridge; Nicola R Sibson; Daniel C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-09       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.